AlphaTON Capital Releases Market Update on Outstanding Shares, Warrants, Options, and RSUs
MWN-AI** Summary
AlphaTON Capital Corp. (NASDAQ: ATON), a leading technology company scaling the Telegram super-app, provided a recent market update regarding its outstanding shares, warrants, options, and restricted share units (RSUs) on February 19, 2026. The company currently has a total of 23,434,588 ordinary shares outstanding, with additional securities that may affect its capital structure.
Specifically, 1,373,686 ordinary shares can be issued through outstanding warrants, which carry a weighted average exercise price of $11.62 per share. Furthermore, there are 1,283,931 ordinary shares linked to pre-funded warrants from a PIPE investment in 2025. The company also holds 316,111 ordinary shares under its 2021 Equity Incentive Plan in the form of options, which have a significantly higher average exercise price of $40.65 per share, along with 5,410 ordinary shares allocated for RSUs.
AlphaTON is strategically positioned within a vast addressable market of 1 billion monthly active Telegram users, advancing comprehensive technology solutions across various sectors, including artificial intelligence and decentralized finance. The company not only supports the Telegram ecosystem but also develops innovative applications and engages in strategic business activities while adhering to the governance standards of a Nasdaq-listed entity.
It is worth noting that this market update also includes forward-looking statements, emphasizing potential risks and uncertainties related to financing, market conditions, and operational strategies, which investors should consider carefully. AlphaTON Capital’s commitment to transparency and governance underlines its ambition to deliver institutional-grade exposure to the evolving technology landscape. For more information, stakeholders are encouraged to visit the company’s official website and social media channels.
MWN-AI** Analysis
AlphaTON Capital Corp. (NASDAQ: ATON) recently released its market update, shedding light on its outstanding shares, warrants, options, and RSUs. The company’s strategic positioning as a leader in technology, particularly its scaling of the Telegram super-app aimed at one billion monthly active users, warrants careful examination for potential and existing investors.
As of February 19, 2026, AlphaTON has a total of approximately 23.4 million ordinary shares outstanding, along with a notable pool of equity incentives including 1.37 million warrants and 1.28 million pre-funded warrants, both carrying weighted average exercise prices of $11.62. It’s crucial for investors to recognize that the warrants may dilute existing shares upon exercise, which can influence stock valuation in the short term.
Additionally, AlphaTON has 316,111 options exercisable under its equity plan, priced significantly higher at $40.65, signaling a bullish outlook from management on future share value. However, this disparity in exercise price may also reveal complexities in management's confidence regarding immediate growth trajectory.
Investors should also take note of the company’s diverse revenue streams, encompassing AI Confidential Compute, decentralized finance platforms, and innovative drug therapies, which collectively enhance its market resilience. However, investors must remain vigilant of the inherent risks associated with its operations and market conditions as highlighted in their recent forward-looking statements.
The technological advancements and strategic framework positioned by AlphaTON signal a robust opportunity for growth; however, entrants should weigh the potential volatility introduced by the exercises of options and warrants against the promising backdrop of their core technology initiatives. Keeping a close watch on market developments and the company's performance updates will be essential for effective portfolio management.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Road Town, Tortola, British Virgin Islands, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) ("AlphaTON" or the "Company"), the world's leading public technology company scaling the Telegram super-app with an addressable market of one billion monthly active users, today announced a market update on its outstanding shares, warrants, options, and RSUs. As of February 19, 2026, the Company has outstanding:
- 23,434,588 ordinary shares
- 1,373,686 ordinary shares issuable upon the exercise of outstanding warrants, with a weighted average exercise price of $11.62 per share;
- 1,283,931 ordinary shares issuable upon the exercise of outstanding pre-funded warrants from PIPE investment in 2025;
- 316,111 ordinary shares issuable upon the exercise of outstanding share options under our 2021 Equity Incentive Plan, with a weighted average exercise price of $40.65 per share; and
- 5,410 ordinary shares issuable upon the vesting of outstanding restricted share units under our 2021 Equity Incentive Plan.
About AlphaTON Capital Corp.
AlphaTON Capital Corp (NASDAQ: ATON) is the world's leading technology public company scaling the Telegram super-app, with an addressable market of 1 billion monthly active users. The Company is delivering a comprehensive hyperscaler strategy on the Telegram ecosystem through a combination of software products, middleware data and AI training assets, and AI infrastructure hardware clusters deploying Confidential AI for the Telegram ecosystem.
Through its operations, AlphaTON Capital provides public market investors with institutional-grade exposure to the Telegram ecosystem and its one billion-user platform while maintaining the governance standards and reporting transparency of a Nasdaq-listed company. The Company's activities span AI Confidential Compute, network validation and staking operations, development of Telegram-based applications including strategic investments and acquisitions of decentralized finance platforms, gaming and markets, and business applications.
AlphaTON Capital Corp is incorporated in the British Virgin Islands and trades on Nasdaq under the ticker symbol "ATON". AlphaTON Capital, through its legacy business, is also advancing first-in-class therapies targeting known checkpoint resistance pathways to achieve durable treatment responses and improve patients' quality of life. AlphaTON Capital actively engages in the drug development process and provides strategic counsel to guide the development of novel immunotherapy assets and asset combinations.
Website: https://alphatoncapital.com
Telegram: https://t.me/alphatoncapital_official
X: https://x.com/AlphaTONCapital
LinkedIn: https://www.linkedin.com/company/alphaton-capital/
Forward-Looking Statements
All statements in this press release, other than statements of historical facts, including without limitation, statements regarding the Company’s business strategy, plans and objectives of management for future operations and those statements preceded by, followed by or that otherwise include the words “believe,” “expects,” “anticipates,” “intends,” “estimates,” “will,” “may,” “plans,” “potential,” “continues,” or similar expressions or variations on such expressions are forward-looking statements. As a result, forward-looking statements are subject to certain risks and uncertainties, including, but not limited to: the risk that the Company may not secure additional financing or TON, the uncertainty of the Company’s investment in TON, the uncertainty around the Company’s legacy business, the operational strategy of the Company, the Company’s executive management team, risks from Telegram’s platform and ecosystem, the potential impact of markets and other general economic conditions, and other factors set forth in “Item 3 – Key Information-Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended March 31, 2025 and included in the Company’s Form 6-Ks filed with the Securities and Exchange Commission on September 3, 2025 and January 13, 2026. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Investor Relations:
John Ragozzino, CFA
AlphaTON@icrinc.com
(203) 682-8200
Media Inquiries:
Richard Laermer
RLM PR
AlphaTON@rlmpr.com
(212) 741-5106 X 216
Richard LaermerAlphaTON(at)rlmpr.com
FAQ**
How does AlphaTON Capital Corp Shs (New) ATON plan to leverage its addressable market of one billion monthly active users on the Telegram platform to drive growth and profitability in the coming years?
What specific risks does AlphaTON Capital Corp Shs (New) ATON foresee in its operations related to the Telegram ecosystem, and how does it plan to mitigate these risks to ensure continued investor confidence?
With the weighted average exercise price for warrants and options being significantly different, how does AlphaTON Capital Corp Shs (New) ATON intend to manage potential dilution of its ordinary shares for existing shareholders?
Can you elaborate on how AlphaTON Capital Corp Shs (New) ATON’s legacy drug development business aligns with its broader technology strategy in the Telegram super-app environment, and what synergies are expected?
**MWN-AI FAQ is based on asking OpenAI questions about AlphaTON Capital Corp Shs (New) (NASDAQ: ATON).
NASDAQ: ATON
ATON Trading
0.41% G/L:
$0.3945 Last:
115,747 Volume:
$0.395 Open:
